Company Filing History:
Years Active: 2024
Title: John Kulman: Innovator in Gene Editing
Introduction
John Kulman is a notable inventor based in South Boston, MA (US). He has made significant contributions to the field of gene editing, particularly in relation to treating conditions associated with angiopoietin-like 3 (ANGPTL3). His innovative work has the potential to impact many lives.
Latest Patents
John Kulman holds a patent for "Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions." This patent focuses on methods, compositions, and kits designed for treating conditions linked to ANGPTL3 through gene editing. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Kulman is currently associated with Crispr Therapeutics AG, a leading company in the field of gene editing. His work at Crispr Therapeutics AG allows him to collaborate with other experts and contribute to groundbreaking advancements in genetic therapies.
Collaborations
Some of his notable coworkers include Yi-Shan Chen and Sandeep Soni. Their collective efforts in the field of gene editing further enhance the innovative environment at Crispr Therapeutics AG.
Conclusion
John Kulman is a prominent figure in the realm of gene editing, with a focus on treating ANGPTL3 related conditions. His contributions and collaborations continue to pave the way for advancements in medical science.